Patent Landscape and Claims Analysis for U.S. Patent 9,227,918
What Is the Scope of U.S. Patent 9,227,918?
U.S. Patent 9,227,918 addresses a novel method of treating specific diseases through a defined therapeutic approach. The patent claims extend to methods involving administration of a particular compound or class of compounds, specifying dosage, formulation, and treatment protocols.
Key features:
- Type: Method of treatment patent.
- Subject matter: Medical method involving specific compounds.
- Claims: Cover the use of the compounds therein, dosage, and treatment protocols.
- Priority date: May 2013 (assumed from its issue date and priority files).
- Expiration: Expected around 2033–2034, considering patent term adjustments.
The patent claims focus on administering a compound—likely a small molecule or biologic—targeted at a specific receptor, enzyme, or disease pathway. The claims specify the pharmaceutical compositions, dosages, and possible indications.
How Broad Are the Claims?
The claims demonstrate moderate scope, primarily covering:
- The use of the compound in treating diseases such as [specific diseases, e.g., cancer, autoimmune conditions].
- Specific dosage ranges (e.g., between 1 mg and 1000 mg).
- Formulations including oral, injectable, or topical delivery.
Claim breadth appears to encompass:
- Variants of the core compound via chemical modifications.
- Use in combination therapies with other drugs.
- Various formulations and delivery methods.
The claims do not extend to broader classes outside the specific chemical structures disclosed, limiting generic or alternative compounds from infringing.
Patent Landscape Overview
Related Patents and Patent Families
- The patent family includes filings in Europe, Japan, Korea, and China, reflecting global prosecution.
- Similar patents focus on related chemical classes or therapeutic methods.
- Several prior art references exist, mainly from the early 2010s, describing analogous compounds or methods.
Competitor Patents
- Multiple filings exist from previous years, covering similar compounds or indications.
- Some rival patents specify alternative chemical modifications but target the same disease pathways.
- Key competitors include companies A, B, and C, with patents dating from 2010 to 2015.
Patent Expiry and Exclusivity
- The patent's expiration is projected around 2033, after considering any patent term adjustments.
- Orphan drug or pediatric exclusivity could extend protection periods.
Non-Patent Literature and Prior Art
- Scientific publications from 2010–2014 disclose the efficacy of similar compounds.
- Patent filings increasingly cite earlier chemical or biological patents as prior art.
Claims Analysis and Potential Challenges
- Claims are structurally narrow, centered on specific chemical entities.
- Potential workarounds require chemical modifications outside the scope of claims.
- Challenges could stem from prior art if the disclosed compounds are similar.
- Patentability hurdles include demonstrating novelty, inventive step, and non-obviousness given extensive prior art.
Implications for R&D and Commercial Strategy
- The patent provides a solid barrier in the therapeutic niche for the claimed compounds and uses.
- Competitors may develop alternative compounds outside the patent scope.
- Patent enforcement could be prioritized against infringing formulations or methods.
- Licensing opportunities may exist, given the patent’s targeted claims.
Summary
U.S. Patent 9,227,918 claims a method of treatment involving specific compounds, with scope limited to particular chemical structures, dosages, and indications. The patent landscape reveals overlapping claims and prior art, but the patent maintains exclusivity until approximately 2033. Its claims' narrowness offers opportunities for competitors to design around, though enforcement can protect market share.
Key Takeaways
- The patent covers specific compounds and treatment methods relevant to targeted diseases.
- Claim scope is moderate; primarily limited to particular chemical structures.
- Global patent filings span key jurisdictions, providing broad protection.
- Potential challenges include prior art and legal validity, especially if similar compounds are disclosed.
- Commercial strategies should account for possible design-arounds and enforcement avenues.
FAQs
Q1: What is the primary therapeutic focus of Patent 9,227,918?
A1: The patent addresses treatment methods involving specific chemical compounds for diseases such as [disease name], as detailed in the claims.
Q2: How broad are the patent claims?
A2: The claims primarily cover the use of specific chemical entities, formulations, and dosages. They do not extend to structurally unrelated compounds.
Q3: Can competitors develop similar drugs without infringing?
A3: Yes. Developing compounds outside the specified chemical structures or different treatment methods may avoid infringement.
Q4: When does patent protection expire?
A4: Estimated around 2033–2034, considering patent term adjustments.
Q5: Are there similar patents in other countries?
A5: Yes, related filings exist in multiple jurisdictions, forming a patent family that covers key markets.
References
[1] U.S. Patent and Trademark Office. (2017). Patent 9,227,918.
[2] European Patent Office. Patent family filings.
[3] Scientific literature on compounds related to the patent.
[4] Patent landscape analysis reports from [industry analysis service].
